Research Paper Volume 14, Issue 10 pp 4471—4485
NcRNAs-mediated P2RX1 expression correlates with clinical outcomes and immune infiltration in patients with breast invasive carcinoma
Figure 3. Survival analysis. (A) Overall survival analysis of P2RX1 expression in BC, CESC, and LUAD using the GIPIA platform. (B) Disease-free survival analysis of P2RX1 expression in BC using the GIPIA platform. (C) Overall survival analysis of P2RX1 expression in BC with the cut-off of the 25th and 75th percentile expression levels.